Cleared Traditional

SUPERVAN 1.5T MAGNETIC RESONANCE IMAGING SYSTEM (K131896) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2014
Decision
248d
Days
Class 2
Risk

K131896 is an FDA 510(k) clearance for the SUPERVAN 1.5T MAGNETIC RESONANCE IMAGING SYSTEM. Classified as System, Nuclear Magnetic Resonance Imaging (product code LNH), Class II - Special Controls.

Submitted by Suzhou Anke Medical System Co., Ltd. (Shanghai, CN). The FDA issued a Cleared decision on February 28, 2014 after a review of 248 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1000 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Suzhou Anke Medical System Co., Ltd. devices

Submission Details

510(k) Number K131896 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 25, 2013
Decision Date February 28, 2014
Days to Decision 248 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
141d slower than avg
Panel avg: 107d · This submission: 248d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LNH System, Nuclear Magnetic Resonance Imaging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1000
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LNH System, Nuclear Magnetic Resonance Imaging

All 431
Devices cleared under the same product code (LNH) and FDA review panel - the closest regulatory comparables to K131896.
MAGNETOM AERA WITH SOFTWARE SYNGO MR E11A, MAGNETOM SKYRA WITH SOFTWARE SYNGO MR E11A, MAGNETOM SKYRA WITH 24 RF CHANNEL
K141977 · Siemens Medical Solutions USA, Inc. · Nov 2014
MAGNETOM Combi Suite Neurosurgery for the MAGNETOM Aera, MAGNETOM Combi Suite Neurosurgery for the MAGNETOM Skyra
K142515 · Siemens Medical Solutions USA, Inc. · Oct 2014
MAGNETOM ARTIS COMBI SUITE FOR THE MAGNETOM AERA/SKYRA/SKYRA WITH TIMTX TRUESHAPE
K140253 · Siemens Medical Solutions USA, Inc. · Mar 2014
MAGNETOM AERA AND SKYRA WITH SOFTWARE MR D13A
K133435 · Siemens Medical Solutions USA, Inc. · Dec 2013
MAGNETOM PRISMA, MAGNETOM PRISMA FIT
K132119 · Siemens Medical Solutions USA, Inc. · Nov 2013
MAGNETOM AERA
K132951 · Siemens Medical Solutions USA, Inc. · Nov 2013